Home Evaluation of thyrotrophic and lactotrophic reserves in patients with pituitary dwarfism with and without empty sella turcica
Article
Licensed
Unlicensed Requires Authentication

Evaluation of thyrotrophic and lactotrophic reserves in patients with pituitary dwarfism with and without empty sella turcica

  • César Geremia ORCID logo EMAIL logo and Felipe Geremia ORCID logo
Published/Copyright: July 21, 2025

Abstract

Objectives

Empty sella turcica (ES) is commonly observed in idiopathic growth hormone deficiency (GHD) in children. This study aims to determine the frequency of ES in children with GHD, assess their pituitary thyroid-stimulating hormone (TSH) and prolactin (PRL) reserves using the thyrotropin-releasing hormone (TRH) stimulation test, and investigate whether ES is associated with a higher prevalence of combined pituitary hormonal deficiencies.

Methods

TSH and PRL pituitary reserves were assessed through the TRH stimulation test in 22 patients with ES and 31 without this finding (non-ES). All participants had childhood-onset GHD and underwent pituitary imaging, primarily by computed tomography (CT) Anti-thyroid peroxidase (anti-TPO) antibodies were measured in all patients with elevated basal TSH.

Results

Among 125 children diagnosed with GHD between 1988 and 1996, ES was identified in 29 cases (23 %). Fifty-three patients agreed to participate (86.8 % male), with ES present in 43.5 % of males and 28.6 % of females. No significant differences in TSH and PRL responses to TRH were observed between the ES and non-ES groups. Mildly elevated basal TSH was observed in 50 % of patients with ES and 55 % without ES, most of who tested negative for anti-TPO antibodies. Among patients with elevated basal TSH and hypothyroidism, the majority exhibited exaggerated or delayed TSH responses to TRH and elevated basal PRL, findings suggestive of hypothalamic dysfunction. Four patients presented combined GH, TSH, and PRL deficiencies.

Conclusions

ES is common in children with GHD but presents distinct features compared to adults. Central hypothyroidism (CeH) was observed in 45.6 % of patients with ES and 54.8 % without ES. Mild TSH elevation was frequent and rarely associated with anti-TPO antibodies, supporting the exclusion of primary hypothyroidism and suggesting underlying hypothalamic dysfunction. Subclinical hormonal abnormalities were also frequent among euthyroid patients. The TRH stimulation test proved valuable in distinguishing hypothalamic dysfunction from pituitary or primary hypothyroidism. Genetic testing for POU1F1 and PROP1 mutations may be warranted in selected cases with combined deficiencies.


Corresponding author: César Geremia, Programa de Pós-Graduação em Saúde da Criança e do Adolescente, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil, E-mail:

Funding source: Fundo de Incentivo àPesquisa e Eventos of the Hospital de ClÃ-nicas de Porto Alegre

Acknowledgments

We extend our deepest gratitude to the late Dr. Regina Helena Elnecave for her invaluable insights and contributions to this study. We also thank the Research and Event Support Fund of the Hospital de Clínicas de Porto Alegre, Brazil, for their financial support in conducting this research.

  1. Research ethics: This study was approved by the Research Ethics Committee of Hospital de Clínicas de Porto Alegre, Brazil.

  2. Informed consent: Patients and their guardians were informed about the research and its objectives and provided written consent by signing an Informed Consent Form.

  3. Author contributions: César Geremia: conceptualization, data curation, investigation, methodology, project administration, writing-original draft preparation, writing-review, and editing. Felipe Geremia: Graphic design, formal analysis, visualization, writing-review, and editing. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: The funding for this study was provided by the Fundo de Incentivo à Pesquisa e Eventos (Research and Events Incentive Fund) linked to the Post-Graduate Studies Group of the Hospital de Clínicas de Porto Alegre, Brazil.

  7. Data availability: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

References

1. Colm Costigan, D, Daneman, D, Harwood-Nash, D, Holland, FJ. The “Empty Sella” in childhood. Clin Pediatr 1984;23:437–40. https://doi.org/10.1177/000992288402300804.Search in Google Scholar PubMed

2. Lenz, AM, Root, AW. Empty sella syndrome. Pediatr Endocrinol Rev 2012;9:710–5.Search in Google Scholar

3. Pocecco, M, de Campo, C, Marinoni, S, Tommasini, G, Basso, T, Muzzolini, C, et al.. High frequency of empty sella syndrome in children with growth hormone deficiency. Helv Paediatr Acta 1989;43:295–301.Search in Google Scholar

4. Kelberman, D, Dattani, MT. Role of transcription factors in midline central nervous system and pituitary defects. In: Endocrine involvement in developmental syndromes. Basel: KARGER; 2009:67–82 pp.10.1159/000207478Search in Google Scholar PubMed

5. Pocecco, M, De Campo, C, Marinoni, S, Tonini, G, Tommasini, G, Schoenle, E. 72 HIGH incidence of primary empty sella syndrome (pess) in children with growth hormone deficiency (GHD). Pediatr Res 1988;24:529–. https://doi.org/10.1203/00006450-198810000-00093.Search in Google Scholar

6. Cacciari, E, Zucchini, S, Ambrosetto, P, Tani, G, Carlà, G, Cicognani, A, et al.. Empty sella in children and adolescents with possible hypothalamic-pituitary disorders. J Clin Endocrinol Metab 1994;78:767–71. https://doi.org/10.1210/jcem.78.3.8126155.Search in Google Scholar PubMed

7. Auer, MK, Stieg, MR, Crispin, A, Sievers, C, Stalla, GK, Kopczak, A. Primary empty sella syndrome and the prevalence of hormonal dysregulation. Dtsch Arztebl Int 2018;115:99–105. https://doi.org/10.3238/arztebl.2018.0099.Search in Google Scholar PubMed PubMed Central

8. Giustina, A, Aimaretti, G, Bondanelli, M, Buzi, F, Cannavò, S, Cirillo, S, et al.. Primary empty sella: why and when to investigate hypothalamic-pituitary function. J Endocrinol Investig 2010;33:343–6. https://doi.org/10.1007/BF03346597.Search in Google Scholar PubMed

9. Maira, G, Anile, C, Mangiola, A. Primary empty sella syndrome in a series of 142 patients. J Neurosurg 2005;103:831–6. https://doi.org/10.3171/jns.2005.103.5.0831.Search in Google Scholar PubMed

10. Chiloiro, S, Giampietro, A, Bianchi, A, De Marinis, L. Empty sella syndrome: multiple endocrine disorders Handb Clin Neurol 2021;181:29–40. https://doi.org/10.1016/B978-0-12-820683-6.00003-8.Search in Google Scholar PubMed

11. Bressani, N, di Natale, B, Pellini, C, Triulzi, F, Scotti, G, Chiumello, G. Evidence of morphological and functional abnormalities in the hypothalamus of growth-hormone-deficient children: a combined magnetic resonance imaging and endocrine study. Horm Res 1990;34:189–92. https://doi.org/10.1159/000181823.Search in Google Scholar PubMed

12. De Marinis, L, Bonadonna, S, Bianchi, A, Maira, G, Giustina, A. Primary empty sella. J Clin Endocrinol Metab 2005;90:5471–7. https://doi.org/10.1210/jc.2005-0288.Search in Google Scholar PubMed

13. Agrawal, NK, Jain, P, Garg, S. Primary empty sella with isolated ACTH deficiency and microprolactinoma. Gynecol Endocrinol 2012;28:568–9. https://doi.org/10.3109/09513590.2011.650663.Search in Google Scholar PubMed

14. Bergland, RM, Ray, BS, Torack, RM. Anatomical variations in the pituitary gland and adjacent structures in 225 human autopsy cases. J Neurosurg 1968;28:93–9. https://doi.org/10.3171/jns.1968.28.2.0093.Search in Google Scholar PubMed

15. Busch, W. Die Morphologie der Sella turcica und ihre Beziehungen zur Hypophyse. Virchows Arch Pathol Anat Physiol Klin Med 1951;320:437–58. https://doi.org/10.1007/BF00957474.Search in Google Scholar PubMed

16. Kaufman, B. The “empty” sella turcica—a manifestation of the intrasellar subarachnoid space. Radiology 1968;90:931–41. https://doi.org/10.1148/90.5.931.Search in Google Scholar PubMed

17. Manavela, MP, Goodall, CM, Katz, SB, Moncet, D, Bruno, OD. The association of Cushing’s disease and primary empty sella turcica. Pituitary 2001;4:145–51. https://doi.org/10.1023/A:1015310806063.10.1023/A:1015310806063Search in Google Scholar

18. Degli Uberti, EC, Teodori, V, Trasforini, G, Tamarozzi, R, Margutti, A, Bianconi, M, et al.. [The empty sella syndrome. Clinical, radiological and endocrinologic analysis in 20 cases]. Minerva Endocrinol 1989;14:1–18.Search in Google Scholar

19. Faglia, G, Beck-Peccoz, P, Ferrari, C, Ambrosi, B, Spada, A, Trevaglini, P, et al.. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 1973;37:595–601. https://doi.org/10.1210/jcem-37-4-595.Search in Google Scholar PubMed

20. Chiloiro, S, Giampietro, A, Bianchi, A, Tartaglione, T, Capobianco, A, Anile, C, et al.. Diagnosis of Endocrine Disease: primary empty sella: a comprehensive review. Eur J Endocrinol 2017;177:R275–85. https://doi.org/10.1530/EJE-17-0505.Search in Google Scholar PubMed

21. Gallardo, E, Schächter, D, Caceres, E, Becker, P, Colin, E, Martinez, C, et al.. The empty sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances. Clin Endocrinol 1992;37:529–33. https://doi.org/10.1111/j.1365-2265.1992.tb01484.x.Search in Google Scholar PubMed

22. Melmed, S, Casanueva, FF, Hoffman, AR, Kleinberg, DL, Montori, VM, Schlechte, JA, et al.. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:273–88. https://doi.org/10.1210/jc.2010-1692.Search in Google Scholar PubMed

23. Snyder, PJ, Jacobs, LS, Rabello, MM, Sterling, FH, Shore, RN, Utiger, RD, et al.. Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Ann Intern Med 1974;81:751. https://doi.org/10.7326/0003-4819-81-6-751.Search in Google Scholar PubMed

24. Ridgway, EC, Kourides, LA, Kliman, B, Bigos, T, Maloof, F. Thyrotropin and prolactin pituitary reserve in the “empty sella syndrome”. J Clin Endocrinol Metab 1975;41:968–73. https://doi.org/10.1210/jcem-41-5-968.Search in Google Scholar PubMed

25. Zucchini, S, Ambrosetto, P, Carla’, G, Tani, G, Franzoni, E, Cacciari, E. Primary empty sella: differences and similarities between children and adults. Acta Paediatr 1995;84:1382–5. https://doi.org/10.1111/j.1651-2227.1995.tb13574.x.Search in Google Scholar PubMed

26. Wilkinson, IA. Empty-sella syndrome. Am J Dis Child 1982;136:245. https://doi.org/10.1001/archpedi.1982.03970390059016.Search in Google Scholar PubMed

27. Besci, Ö, Yaşar, E, Erbaş, İM, Acınıklı, KY, Demir, K, Böber, E, et al.. Clinical course of primary empty sella in children: a singlecenter experience. Turk J Pediatr 2022;64:900–8. https://doi.org/10.24953/turkjped.2021.4953.Search in Google Scholar PubMed

28. Elnecave, RH, Gross, JL, Livi, AL. Empty sella syndrome is related to greater growth retardation in growth hormone-deficient patients. Las Vegas; 1993.Search in Google Scholar

29. Gaillard, F, Weerakkody, Y, Walizai, T. Empty sella. Radiopaedia.org; 2012.10.53347/rID-17774Search in Google Scholar

30. Saindane, AM, Lim, PP, Aiken, A, Chen, Z, Hudgins, PA. Factors determining the clinical significance of an “empty” sella turcica. Am J Roentgenol 2013;200:1125–31. https://doi.org/10.2214/AJR.12.9013.Search in Google Scholar PubMed

31. Sage, MR, Blumbergs, PC. Primary empty sella turcica: a radiological– anatomical correlation. Australas Radiol 2000;44:341–8. https://doi.org/10.1046/j.1440-1673.2000.00828.x.Search in Google Scholar PubMed

32. Akkus, G, Sözütok, S, Odabaş, F, Onan, B, Evran, M, Karagun, B, et al.. Pituitary volume in patients with primary empty sella and clinical relevance to pituitary hormone secretion: a retrospective single center study. Current Medical Imaging Formerly Current Medical Imaging Reviews 2021;17:1018–24. https://doi.org/10.2174/1573405617666210525111218.Search in Google Scholar PubMed PubMed Central

33. Haughton, V, Rosenbaum, A, Williams, A, Drayer, B. Recognizing the empty sella by CT: the infundibulum sign. Am J Roentgenol 1981;136:293–5. https://doi.org/10.2214/ajr.136.2.293.Search in Google Scholar PubMed

34. Abucham, J, Castro, V, Maccagnan, P, Vieira, JGH. Increased thyrotrophin levels and loss of the nocturnal thyrotrophin surge in Sheehan’s syndrome. Clin Endocrinol 1997;47:515–22. https://doi.org/10.1046/j.1365-2265.1997.2381042.x.Search in Google Scholar PubMed

35. Abboud, CF. Laboratory diagnosis of hypopituitarism. Mayo Clin Proc 1986;61:35–48. https://doi.org/10.1016/S0025-6196(12)61397-4.Search in Google Scholar

36. Persani, L, Brabant, G, Dattani, M, Bonomi, M, Feldt-Rasmussen, U, Fliers, E, et al.. 2018 European thyroid association (ETA) guidelines on the diagnosis and management of central hypothyroidism. Eur Thyroid J 2018;7:225–37. https://doi.org/10.1159/000491388.Search in Google Scholar PubMed PubMed Central

37. Persani, L, Cangiano, B, Bonomi, M. The diagnosis and management of central hypothyroidism in 2018. Endocr Connect 2019;8:R44–54. https://doi.org/10.1530/EC-18-0515.Search in Google Scholar PubMed PubMed Central

38. Oliveira, JHA, Persani, L, Beck-Peccoz, P, Abucham, J. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan’s syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 2001;86:1694–9. https://doi.org/10.1210/jcem.86.4.7373.Search in Google Scholar PubMed

39. Fröhlich, E, Wahl, R. The forgotten effects of thyrotropin-releasing hormone: metabolic functions and medical applications. Front Neuroendocrinol 2019;52:29–43. https://doi.org/10.1016/j.yfrne.2018.06.006.Search in Google Scholar PubMed

40. Beck-Peccoz, P, Amr, S, Menezes-Ferreira, MM, Faglia, G, Weintraub, BD. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. N Engl J Med 1985;312:1085–90. https://doi.org/10.1056/NEJM198504253121703.Search in Google Scholar PubMed

41. Horimoto, M, Nishikawa, M, Ishihara, T, Yoshikawa, N, Yoshimura, M, Inada, M. Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3’-triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 1995;80:1124–8. https://doi.org/10.1210/jcem.80.4.7714080.Search in Google Scholar PubMed

42. Persani, L, Ferretti, E, Borgato, S, Faglia, G, Beck-Peccoz, P. Circulating thyrotropin bioactivity in sporadic central Hypothyroidism1. J Clin Endocrinol Metab 2000;85:3631–5. https://doi.org/10.1210/jcem.85.10.6895.Search in Google Scholar PubMed

43. Iglesias, P. Central hypothyroidism: advances in etiology, diagnostic challenges, therapeutic targets, and associated risks. Endocr Pract 2025;31:650–9. https://doi.org/10.1016/j.eprac.2025.02.004.Search in Google Scholar PubMed

44. Patel, YC, Burger, HG. Serum thyrotropin (TSH) in pituitary and/or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1973;37:190–6. https://doi.org/10.1210/jcem-37-2-190.Search in Google Scholar PubMed

45. Persani, L. Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 2012;97:3068–78. https://doi.org/10.1210/jc.2012-1616.Search in Google Scholar PubMed

46. Faglia, G. The clinical impact of the thyrotropin-releasing hormone test. Thyroid 1998;8:903–8. https://doi.org/10.1089/thy.1998.8.903.Search in Google Scholar PubMed

47. Spencer, CA, Schwarzbein, D, Guttler, RB, LoPresti, JS, Nicoloff, JT. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 1993;76:494–8. https://doi.org/10.1210/jcem.76.2.8432796.Search in Google Scholar PubMed

48. Costom, BH, Grumbach, MM, Kaplan, SL. Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. J Clin Investig 1971;50:2219–25. https://doi.org/10.1172/JCI106717.Search in Google Scholar PubMed PubMed Central

49. Fliers, E, Bianco, AC, Langouche, L, Boelen, A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol 2015;3:816–25. https://doi.org/10.1016/S2213-8587(15)00225-9.Search in Google Scholar PubMed PubMed Central

50. Wartofsky, L, Burman, KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev 1982;3:164–217. https://doi.org/10.1210/edrv-3-2-164.Search in Google Scholar PubMed

51. Korevaar, TIM, Medici, M, Visser, TJ, Peeters, RP. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol 2017;13:610–22. https://doi.org/10.1038/nrendo.2017.93.Search in Google Scholar PubMed

52. Grimberg, A, Feemster, KA, Pati, S, Ramos, M, Grundmeier, R, Cucchiara, AJ, et al.. Medically underserved girls receive less evaluation for short stature. Pediatrics 2011;127:696–702. https://doi.org/10.1542/peds.2010-1563.Search in Google Scholar PubMed PubMed Central

53. Grimberg, A, Stewart, E, Wajnrajch, MP. Gender of pediatric recombinant human growth hormone recipients in the United States and globally. J Clin Endocrinol Metab 2008;93:2050–6. https://doi.org/10.1210/jc.2007-2617.Search in Google Scholar PubMed PubMed Central

54. Jorge, AAL, Grimberg, A, Dattani, MT, Baron, J. Disorders of childhood growth. In: Sperling, MA, editor. Sperling pediatric endocrinology, 5th ed.; 2021:299–356 pp.10.1016/B978-0-323-62520-3.00011-7Search in Google Scholar

55. Faglia, G, Bitensky, L, Pinchera, A, Ferrari, C, Paracchi, A, Beck-Peccoz, P, et al.. Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 1979;48:989–98. https://doi.org/10.1210/jcem-48-6-989.Search in Google Scholar PubMed

56. Kempers, MJE, Lanting, CI, van Heijst, AFJ, van Trotsenburg, ASP, Wiedijk, BM, de Vijlder, JJM, et al.. Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab 2006;91:3370–6. https://doi.org/10.1210/jc.2006-0058.Search in Google Scholar PubMed

57. Alatzoglou, KS, Dattani, MT. Genetic causes and treatment of isolated growth hormone deficiency—an update. Nat Rev Endocrinol 2010;6:562–76. https://doi.org/10.1038/nrendo.2010.147.Search in Google Scholar PubMed

58. Beck-Peccoz, P, Persani, L. Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 1994;131:331–40. https://doi.org/10.1530/eje.0.1310331.Search in Google Scholar PubMed

59. Koulouri, O, Moran, C, Halsall, D, Chatterjee, K, Gurnell, M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metabol 2013;27:745–62. https://doi.org/10.1016/j.beem.2013.10.003.Search in Google Scholar PubMed PubMed Central

60. Correa, FA, Nakaguma, M, Madeira, JLO, Nishi, MY, Abrão, MG, Jorge, AAL, et al.. Combined pituitary hormone deficiency caused by PROP1 mutations: update 20 years post-discovery. Arch Endocrinol Metab 2019;63:167–74. https://doi.org/10.20945/2359-3997000000139.Search in Google Scholar PubMed PubMed Central

61. Pfäffle, RW, DiMattia, GE, Parks, JS, Brown, MR, Wit, JM, Jansen, M, et al.. Mutation of the POU-specific domain of pit-1 and hypopituitarism without pituitary hypoplasia. Science. 1992;257:1118–21. https://doi.org/10.1126/science.257.5073.1118.Search in Google Scholar PubMed

62. Mehta, A, Hindmarsh, PC, Stanhope, RG, Brain, CE, Preece, MA, Dattani, MT. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 2003;88:5696–703. https://doi.org/10.1210/jc.2003-030943.Search in Google Scholar PubMed

63. Lania, A, Persani, L, Beck-Peccoz, P. Central hypothyroidism. Pituitary 2008;11:181–6. https://doi.org/10.1007/s11102-008-0122-6.Search in Google Scholar PubMed

64. Beck-Peccoz, P, Rodari, G, Giavoli, C, Lania, A. Central hypothyroidism – a neglected thyroid disorder. Nat Rev Endocrinol 2017;13:588–98. https://doi.org/10.1038/nrendo.2017.47.Search in Google Scholar PubMed

65. Persani, L. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metabol 2000;85:3631–5. https://doi.org/10.1210/jc.85.10.3631.Search in Google Scholar

66. Christensen, SE, Smith, LN, Rosendal, CAH, Gulisano, HA, Ettrup, KS, Vestergaard, P, et al.. The TRH test provides valuable information in the diagnosis of central hypothyroidism in patients with known pituitary disease and low T4 levels. Front Endocrinol 2023;14. https://doi.org/10.3389/fendo.2023.1226887.Search in Google Scholar PubMed PubMed Central

67. Yoo, MH, Kim, HJ, Park, S, Park, SJ, Park, HK, Byun, DW, et al.. Role of thyrotropin-releasing hormone stimulation test and autoantibody in 952 subjects with subclinical hypothyroidism. J Endocr Soc 2024;9. https://doi.org/10.1210/jendso/bvae212.Search in Google Scholar PubMed PubMed Central

68. Ebuchi, Y, Kubo, T, Furujo, M, Higuchi, Y, Fujinaga, S, Tsuchiya, H, et al.. Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test. J Pediatr Endocrinol Metabol 2020;33:1417–23. https://doi.org/10.1515/jpem-2020-0151.Search in Google Scholar PubMed

69. Yamamoto, A, Iwanaga, K, Matsukura, T, Niwa, F, Morimoto, T, Takita, J, et al.. Response of preterm infants with transient hypothyroxinaemia of prematurity to the thyrotropin-releasing hormone stimulation test is characterized by a delayed decrease in thyroid-stimulating hormone after the peak. Clin Endocrinol 2020;93:605–12. https://doi.org/10.1111/cen.14260.Search in Google Scholar PubMed

70. Grunenwald, S, Caron, P. Central hypothyroidism in adults: better understanding for better care. Pituitary 2015;18:169–75. https://doi.org/10.1007/s11102-014-0559-8.Search in Google Scholar PubMed

71. Rapaport, R, Akler, G, Regelmann, MO, Greig, F. Time for thyrotropin releasing hormone to return to the United States of America. Thyroid 2010;20:947–8. https://doi.org/10.1089/thy.2010.1656.Search in Google Scholar PubMed

72. Atmaca, H, Tanriverdi, F, Gokce, C, Unluhizarci, K, Kelestimur, F. Do we still need the TRH stimulation test? Thyroid 2007;17:529–33. https://doi.org/10.1089/thy.2006.0311.Search in Google Scholar PubMed

73. DiVall, SA, Wondisford, FE. TRH testing in its infancy. J Clin Endocrinol Metab 2008;93:378–9. https://doi.org/10.1210/jc.2007-2648.Search in Google Scholar PubMed

74. Moncayo, H, Dapunt, O, Moncayo, R. Diagnostic accuracy of basal TSH determinations based on the intravenous TRH stimulation test: an evaluation of 2570 tests and comparison with the literature. BMC Endocr Disord 2007;7:5. https://doi.org/10.1186/1472-6823-7-5.Search in Google Scholar PubMed PubMed Central

Received: 2025-02-17
Accepted: 2025-07-10
Published Online: 2025-07-21
Published in Print: 2025-09-25

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Mini Review
  3. Transition of care from childhood/adolescence to adulthood in familial hypercholesterolemia
  4. Original Articles
  5. Performance of adult height prediction methods in 6 to 8-year-old girls with GnRH-dependent precocious puberty
  6. Height velocity in the detection of growth disorders reconsidered: a retrospective analysis of the DONALD study
  7. Differentiating transient and permanent congenital hypothyroidism: predictive clues from Istanbul, Türkiye
  8. Evaluation of thyrotrophic and lactotrophic reserves in patients with pituitary dwarfism with and without empty sella turcica
  9. Exploring the impact of androgen levels on depression and anxiety in adolescent females: a clinical perspective
  10. The diagnostic value of stimulated androgen ratios in 5-alpha reductase type 2 (SRD5A2) deficiency: a case series and review of the literature
  11. Prolonged symptom duration and the potential for gradual progression in pediatric adrenocortical tumors: observations from the MET studies
  12. Distinguishing organic from idiopathic central precocious puberty: clinical characteristics and predictive factors for organic etiology in a multicenter Italian cohort study
  13. Endocrinopathies associated with pediatric common variable immunodeficiency
  14. Genetic, neuroimaging, and clinical characteristics of a cohort of individuals with L-2-hydroxyglutaric aciduria from Türkiye
  15. Short Communications
  16. Stress hyperglycemia in pediatric patients as a risk factor for type 1 diabetes – a single center experience
  17. Observations of the effect of gonadotropin-releasing hormone analog treatment on psychosocial well-being in transgender youth and their caregivers – a pilot study
  18. Letter to the Editor
  19. GNB1 haploinsufficiency presents as monogenic obesity syndrome
  20. Case Reports
  21. Rare pediatric insulinoma case diagnosed by endoscopic ultrasonography: insights into endogenous hyperinsulinemic hypoglycemia
  22. Caudal epidural steroid injection as a novel therapy for treatment-induced neuropathy of diabetes in children: report of two cases
  23. A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes
  24. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: case report of a child with rare HMGCL gene variants
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2025-0082/html
Scroll to top button